Medicine:DTP vaccine
_immunization,_OWID.svg) Global vaccination coverage- diphtheria-tetanus-pertussis (DTP3) immunization[1] | |
| Combination of | |
|---|---|
| Diphtheria | Vaccine |
| Tetanus | Vaccine |
| Pertussis | Vaccine |
| Clinical data | |
| Trade names | REVAXIS |
| AHFS/Drugs.com | UK Drug Information |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
DTP is a combination vaccine against three infectious diseases in humans: diphtheria, tetanus, and Pertussis. This is used in the United Kingdom , the Netherlands, and France .
Brand names include REVAXIS (Sanofi Pasteur).[2]
By country
In the United Kingdom, DTP is called the "3-in-1 teenage booster" and protects against tetanus, diphtheria and polio. It is given by the NHS to all teenagers aged 14. (The hexavalent vaccine is given to infants and provides the first stage of protection against diphtheria, tetanus, and polio, as well as pertussis, Haemophilus influenzae type B and Hepatitis B). Subsequent boosters are recommended for foreign travellers where more than 10 years has passed since their last booster.[3] This is provided on the NHS free of charge due to the significant risk that an imported case of polio could pose to public health in Britain.[4]
In France, DTP is given at 11 months, 11-13 years, then at ages 25, 45, 65, then every ten years.[5]
In the Netherlands, DTP is given as part of the National Immunisation Programme.
References
- ↑ "Global vaccination coverage: Diphtheria-tetanus-pertussis (DTP3) immunization". https://ourworldindata.org/grapher/diphtheria-tetanus-pertussis-dtp3-immunization-global. Retrieved 5 March 2020.
- ↑ NHS https://www.nhs.uk/conditions/vaccinations/3-in-1-teenage-booster/
- ↑ https://www.nhs.uk/conditions/tetanus/
- ↑ https://www.nhs.uk/conditions/travel-vaccinations/
- ↑ Republique Francaise https://www.service-public.fr/particuliers/vosdroits/F704
 |
